Go to the list of all blogs
Alicia's Avatar
published in Blogs
Feb 27, 2026
TickeronGET DAILY SIGNALS
Why Carter’s (CRI) Dropped -21%: A Solid Holiday Quarter Buried Under a Bleak 2026 EPS Outlook

Why Carter’s (CRI) Dropped -21%: A Solid Holiday Quarter Buried Under a Bleak 2026 EPS Outlook

Why Did Carter’s (CRI) Stock Fall Over 21% Today?

Carter’s (CRI) dropped more than 21% today because, even though it beat Q4 expectations on both sales and earnings, management issued a much weaker 2026 earnings outlook, highlighted ongoing margin pressure from tariffs and product costs, and guided to a sharp near‑term EPS drop that jarred investors.

Key Takeaways

  • Q4 2025 sales were about 925 million dollars, beating estimates and up mid‑single digits year over year (helped by an extra week), and adjusted EPS of 1.90 dollars topped the roughly 1.55–1.60 dollar consensus.

  • Despite this beat, adjusted EPS fell 20.5% from last year, and operating margin compressed by about 50 basis points to 9.2% as higher tariffs, product costs, and incentives ate into profitability.

  • For 2026, management guided to a low double‑digit to mid‑teens decline in adjusted EPS from 3.47 dollars in 2025 and forecast Q1 EPS of just 0.02–0.08 dollars versus 0.66 dollars last year, far below Wall Street expectations.

  • Higher tariffs, mix shifts, weaker cash flow (2025 operating cash flow dropped to 122 million dollars from 299 million), and lingering wholesale and retail pressures fed worries that Carter’s earnings power is structurally lower than before.

Q4 Looked Good on the Surface

Carter’s delivered a headline beat in Q4 2025. Revenue came in around 925 million dollars, up roughly 7–8% year over year and above consensus near 904 million dollars, with growth across U.S. retail, international, and wholesale. Part of that growth reflected a 53rd week in the fiscal year, which management said added about 37 million dollars of sales, so underlying growth was closer to 3–4%.

Adjusted EPS was 1.90 dollars, handily beating expectations of roughly 1.55–1.60 dollars. Operating income ticked up about 1.8% to roughly 84.7 million dollars, but the operating margin slipped to 9.2% from 9.7% as the company absorbed higher input costs and tariffs. On a full‑year basis, revenue rose to about 2.9 billion dollars, yet GAAP diluted EPS dropped to 2.53 dollars from 5.12, and adjusted EPS fell to 3.47 dollars, underscoring how much profitability has compressed even as sales held up.

Guidance Shock: 2026 EPS Set to Fall

The real problem was what Carter’s said about the future. Management guided 2026 adjusted EPS to about 2.91 dollars, implying a low double‑digit to mid‑teens percentage decline from 3.47 dollars in 2025, even though they expect low‑ to mid‑single‑digit net sales growth. In practical terms, that means revenue may inch up, but rising costs and tariffs will continue to squeeze profits.

The near‑term outlook was even more jarring. For Q1 2026, Carter’s projected adjusted EPS of just 0.02–0.08 dollars, compared with 0.66 dollars in the prior‑year quarter and consensus near 0.36 dollars—one of the largest negative EPS guide gaps in the consumer space this season. Management cited higher tariffs, elevated product costs as they invest in product “make,” promotional intensity, and deleverage in both U.S. retail and wholesale as key headwinds.

Investors had already been wrestling with conflicting analyst views: some saw Carter’s as a value play, while others warned that longer‑term forecasts point to flat‑to‑down revenue and significantly lower earnings by 2028. Today’s guidance effectively endorsed the more pessimistic camp, confirming that margin and EPS pressures are not just a 2025 blip.

Margin Pressure, Tariffs, and Weak Cash Flow

Beyond EPS guidance, several underlying trends raised red flags. Adjusted operating income for 2025 fell by about 26 million dollars, and the adjusted operating margin dropped from roughly 13.4% to 9.7%, driven largely by lower profitability in U.S. retail and wholesale segments. Management highlighted the “lion’s share” of the decline came from higher tariffs and product costs, along with wage and incentive pressures.

Cash flow also deteriorated meaningfully. Operating cash flow fell to roughly 122 million dollars in 2025 from about 299 million dollars the year before, mainly due to higher inventories and reduced earnings. That weaker cash generation, combined with refinancing activity and a new 750‑million‑dollar asset‑based revolver, reinforced the sense that Carter’s is operating with less financial flexibility than in the past.

Although management is executing productivity actions—cutting about 300 office jobs, planning roughly 150 store closures over three years, and targeting 35 million dollars in annual savings plus more than 10 million dollars in SG&A cuts—those benefits will take time to fully materialize and may be partially offset by ongoing cost and tariff headwinds.

Why the Stock Fell Over 21% Today

When you combine a Q4 beat with:

  • A 20% year‑over‑year drop in adjusted EPS,

  • A big decline in operating and cash‑flow margins, and

  • A 2026 EPS outlook that calls for another low‑teens percentage decline,

you get a classic “good quarter, bad future” setup.

Traders quickly repriced CRI to reflect structurally lower earnings power. The stock slid from the mid‑40s into the low‑30s, a drop of more than 20%, putting it near its 52‑week lows despite what appears, at first glance, to be solid holiday‑quarter results. In short, Carter’s didn’t fall because Q4 was weak; it fell because management confirmed that profits are likely to keep shrinking in 2026, and the market is no longer willing to ignore that reality.

Tickeron AI Perspective

 Disclaimers and Limitations

Related Ticker: CRI

Contributor

Alicia's AvatarAlicia|Beginner

CRI's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CRI turned positive on November 04, 2026. Looking at past instances where CRI's MACD turned positive, the stock continued to rise in 40 of 55 cases over the following month. The odds of a continued upward trend are 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on CRI as a result. In 62 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.

CRI moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CRI crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.

Following a +3.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRI advanced for three days, in 194 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

The Aroon Indicator entered an Uptrend today. In 109 of 189 cases where CRI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 58%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.

CRI broke above its upper Bollinger Band on November 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.144) is normal, around the industry mean (1.858). P/E Ratio (5.972) is within average values for comparable stocks, (12.576). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (0.517). Dividend Yield (0.031) settles around the average of (0.067) among similar stocks. P/S Ratio (0.346) is also within normal values, averaging (0.652).

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. CRI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

Notable companies

The most notable companies in this group are TJX Companies (NYSE:TJX), lululemon athletica (NASDAQ:LULU), Gap Inc (The) (NYSE:GAP), Abercrombie & Fitch Co (NYSE:ANF), Stitch Fix (NASDAQ:SFIX).

Industry description

Companies in the apparel and/or footwear retail industry sell clothing, accessories and footwear, for different age groups and genders. The industry’s product categories could range from basics, such as underwear, to luxury items. Some retailers source items from wholesalers or an apparel brand to sell in their stores; some others are licensed to make and market their own retail goods under particular brands. Several companies outsource production of clothing to developing/emerging economies where labor costs are relatively inexpensive. Apparel retail is often influenced by fashion trends, and many companies feel the need to adapt to what’s “in vogue” to retain customers and attract new ones. A major disruption in this industry has been the burgeoning trend in digital shopping – to compete with rapidly growing e-commerce, even traditional retail players are upping the ante on their online platforms. Much of the products’ performance in apparel/footwear retail is cyclical, i.e., economic boom times encourage consumer spending, while recessions induce thriftiness among people. Some large-cap U.S. apparel/footwear retail companies include TJX Companies Inc., Ross Stores, Inc., Lululemon Athletica Inc. and Burlington Stores, Inc.

Market Cap

The average market capitalization across the Apparel/Footwear Retail Industry is 8.95B. The market cap for tickers in the group ranges from 131.6K to 189.04B. IDEXF holds the highest valuation in this group at 189.04B. The lowest valued company is DESTQ at 131.6K.

High and low price notable news

The average weekly price growth across all stocks in the Apparel/Footwear Retail Industry was -6%. For the same Industry, the average monthly price growth was -9%, and the average quarterly price growth was -13%. MYSZ experienced the highest price growth at 28%, while LVLU experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Apparel/Footwear Retail Industry was 100%. For the same stocks of the Industry, the average monthly volume growth was 154% and the average quarterly volume growth was 72%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 44
P/E Growth Rating: 52
Price Growth Rating: 60
SMR Rating: 64
Profit Risk Rating: 85
Seasonality Score: 18 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of apparel and related products for babies and young children

Industry ApparelFootwearRetail

Industry
Apparel Or Footwear Retail
Address
3438 Peachtree Road North East
Phone
+1 678 791-1000
Employees
15400
Web
https://www.carters.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.